A9589 Insti hexaminolevulinate hcl

Instillation, hexaminolevulinate hydrochloride, 100 mg

Medically Unlikely Edits (effective October 1, 2026)

Medicare pricing for A9589

Medicare Part B drug payment limit (ASP, October 2026)

A9589 payment limit: $1,431.00 per 100 MG, effective October 1, 2026 through December 31, 2026, based on 2Q26 ASP data. Coinsurance 20%.

NDCs that bill under A9589 (CMS ASP NDC-HCPCS crosswalk, October 2026)

Physician Fee Schedule (CY 2026, RVU26D)

Status X: statutory exclusion, not paid under the PFS.

Payer policies and prior authorization for A9589

Medicaid fee-for-service

Prior authorization required or conditional in IN.

  • AZ: $1432.34 (outpatient_hospital), effective Jul 1, 2026
  • CO: $928.74 (chp_plus, non-facility), effective Jul 1, 2026
  • KY: $0.00 (asc), effective Jan 1, 2026
  • NE: $1432.33 (injectables), effective Jul 1, 2026
  • OH: $1432.34 (provider_administered_drugs), effective Jul 1, 2026
  • OK: $1341.10 (physician, non-facility), effective Jul 1, 2026
  • TX: $1310.79 (nurse_practitioner_clinical_nurse_specialist, Nurse Practitioner/Clinical Nurse Specialist, non-facility), effective Sep 1, 2026
  • VA: $1432.33 (medical), effective Jul 1, 2026
  • VT: $0.00 (outpatient_hospital_opps), effective Feb 1, 2026
  • WY: $0.00 (outpatient_hospital_apc, Children's Hospitals), effective Apr 1, 2026

From payers' published prior-auth lists, coverage policies and state Medicaid fee schedules, updated Oct 16, 2026. The role is what the policy's own code table or text says about the code. Not a guarantee of coverage or payment; verify with the payer. CPT® is a registered trademark of the American Medical Association.